SECUKINUMAB (Cosentyx®)

Clinical Indication

Treating moderate to severe plaque psoriasis in children and young people

Comments

In line with NICE TA734

Implementation date  7th January 2022

Date of classification

December 2021

Review date

December 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.